this page only  
Join BIO   |   Member Directory   |    Contact BIO    
Biotechnology Industry Organization
Bio Photo

Home
About BIO
Members.BIO.org
BIO News Online
BIO Bulletins
Suggestion Box
Membership Directory
BIO Videos
News & Media
National Issues
Health Care
Food & Agriculture
Industrial & Environmental
Bioethics
Intellectual Property
Regulatory
Tax & Financial
State & Local Issues
State by State Initiatives
Letters, Testimony & Comments
Speeches & Publications
Industry At-a-Glance
Conferences & Events
Business & Finance


Wednesday, July 09, 2008

12 Years of Hard Work, Setbacks, Problems, Hurdles ...and One Triumph.

Click here for a printer-friendly page Printer Friendly PDF

Call us Stubborn.

Each medicine developed by Biotechnology Companies is a work of perseverance.
[graph: Biotech Drug Discovery Process]

For every drug that makes it to market, four never do. This may not seem like a good success rate, but for the patients who benefit from them, it is.

In the last ten years we introduced more than one hundred sixty new medicines treating conditions such as Cancer, Arthritis and Multiple Sclerosis.
[table: Approved Biotech Drugs: July 1994-June 2004]

These medicines are different. They are biotech drugs.

These state-of-the-art treatments are usually administered in hospitals or doctors' offices. They have taken America's best biotech researchers years to develop. Biotech drugs are often the only effective treatment for many life-threatening diseases.
[table: Approved Orphan Indications: July 1994-June 2004]

These medicines have helped millions of people in the past decade.

Thinking Differently, Changing the World

Related Resources:
Biotech Drug Discovery Process (graph)
Approved Biotech Drugs: July 1994-June 2004 (table)
Approved Orphan Indications: July 1994-June 2004 (table)

© 2008 | Biotechnology Industry Organization | 1201 Maryland Ave., SW, Ste. 900 | Washington, D.C. 20024